General Surgery Flashcards
- How would you go about investigating a 60 year old lady who presented to you having found a lump, about 2cm across, in her left breast?
- History
- Examination
- Imaging
- Biopsy (FNA/Core)
63.Key points of history taking re: lump in breast tissue? (9)
- Lump location, size, changes, first noticed, tender, associated skin changes
- Hx of breast lumps, cysts, fibroadenomas,
- Menstrual hx,
- Medications, including the contraceptive pill and HRT
- Fx hx, including relatives affected by cancers
- Ethnic background
- Risks that suggest genetic susceptibility, such as family history, male breast cancer.
- Trauma – accidental/iatrogenic
- Systemic symptoms
- Examination technique re: lump in breast tissue
Inspection
- Hands by side and above head
- Breast contour
- Skin changes: erythema, dimpling, puckering, peau d’orange
- Nipple changes: inversion, distortion, eczema, nodules, ulders, discharge
Palpation
- Four quadrants with a systematic approach
- Nipple
- Axillary tail
- Lymph nodes
- Axillary and supraclavicular
Imaging requests re: lump in breast tissue (5)
- Mammography
- Investigation of choice if >30yrs
- USS should always accompany to increase accuracy -
- US <30yrs
- MRI
- Is only funded under medicare for high-risk women (e.g. BRCA1/BRCA2 mutation carrier
- CT (preoperative staging)
- Bone scan (preoperative staging)
Algorithm for managing a breast symptom or screening abnormality
What are the risk factors for breast cancer? (11)
- increasing age
- family hx (1st>2nd degree relatives, onset, bilaterality, BRCA1/2 (autosomal dominant)
- previous hx of breast cancer or carcinoma in-situ
- early age of menarche (<12 years)
- late age of menopause (age >55years)
- late age at first full time pregnancy (age <20 years protective)
- nulliparity
- previous breast biopsies showing non-malignant abn. (ductal carcinoma insitu, lobar carcinoma in situ, atypical ductal hyperplasia
- hormal therapy - OCP, HRT
- Radiation at a young age
- physical activity (reduces circulation of oestrogren)
- chronic alcohol intake
List the options for adjuvant treatment for breast cancer (5)
- radiotherapy
- hormone therapy (tamoxifen, aromatase inhibitors)
- chemotherapy (Anthracyclines, taxanes)
- adjuvant anti-HER2 treatment (Trastuzumab - Herceptin)
- Others (Aspirin, Bisphosphonates,Neoadjuvant treatment, lifestyle, radiotherapy)
Define Adjuvant Therapy
Aims at adding to definitive treatment to reduce the risk of both local recurrence and distant metastases in patients in whom there is a high risk of occult disease (micrometastases)
Describe Tamoxifen (Hormone Therapy) in Breast Cancer
- MOA
- Blocks oestrogen receptor inside the breast cancer cell. This stops oestrogen making the breast cancer cell grow.
- Course
- 1 daily tablet, 5 year course after other treatments
- Benefits
- Reduces risk of early breast cancer, new breast cancer developing. Can be used with other treatments for breast cancer like radiotherapy and chemotherapy
- Strengthens bones rather than reducing bone density (unlike aromatase inhibitors can)
- May lower cholesterol and reduce the risk of developing heart disease
- Works either before or after menopause.
- Agonist at bones and endometrial tissue (endometrial cancer)
- Side effects
- Does not cause menopause but side effects may be similar
- Common
- Hot flushes and sweats
- Irregular vaginal bleeding in women who have not been through menopause
- Vaginal irritation, dryness or discharge
- Fluid retention and weight gain
- rare
- DVT, PE (similar risk to OCP)
- Fertility
- Do not become pregnant or breast feed for 1-2 months after stopping.
- Can increase fertility so must use barrier contraception (do not take OCP with tamoxifen)
- Can interact with warfarin
Describe Aromatase Inhibitors (Hormone Therapy) in Breast Cancer
- First line and only work in post-menopausal women with PR or ER positive cancers.
- Cannot use in pre-menopausal as it muffs up negative feedback to pituitary and makes things worse ☹
- MOA
- Blocks aromatase, which helps make oestrogen in body tissues such as muscle, fat and the adrenal glands.
- course
- Tablets taken once daily
- Usual treatment course 5 years.
- Anastrazole, letrozole, exemestane
- Benefits
- Reduce risk of early breast cancer coming back, reduce risk of new breast cancer developing
- Can be used with radio/chemotherapy
- Can be substituted for tamoxifen in post-menopausal women
- Less likely to cause DVT/PE or cancer of the endometrium than tamoxifen.
- Side effects
- Common
- Muscle aches and pains
- Hot flushes
- Vaginal dryness
- Common
- Contraindications
- Osteoporosis
- Follow-ups
- Check Vit D levels, take daily calcium and Vit D supplements
- Yearly bone scan
Describe Tratsuzumab (Adjuvant anti-HER2 treatment) in Breast Cancer
- monoclonal antibody directed against the extracellular domain of human growth factor receptor 2 (HER2), a tyrosine kinase involved in cell growth and proliferation
- prognosis
- HER2 pos à worse prognosis
- Clinical trials:
- use of trastuzumab with chemotherapy improves disease-free and overall survival.
- Side effects
- Main risk is cardiac toxicity (up to 4%), hence baseline and surveillance echocardiograms are required.
- Contraindicated
- Anthracycline (due to cardiac toxicity)
Describe other adjuvant Therapies for Breast Cancer
- Aspirin
- Recent data from a large population cohort study suggests aspirin has a role in prevention of recurrence, although no randomised data exists and optimal dose is undefined.
- Bisphosphonates
- Six-monthly IV, or weekly orally,
- Lowers cancer recurrence (both bone and other organs)
- Direct anti-tumour effect is in keeping with that seen in metastatic breast cancer
- Neoadjuvant treatment
- Chemotherapy, hormone therapy, trastzumab may be considered for large or locally advanced tumours.
- Lifestyle factors
- Healthy diet
- Regular exercise
- Healthy weight range
- Radiotherapy
- After surgery
- Down staging for neoadjuvant
- supportive care
- cancer-centre psychologists
- information packs through National Breast and Ovarian cancer centre and cancer council websites
- support groups
- When is systemic therapy used in breast cancer?
- What are the surgical options for a small confirmed cancer which is sited laterally in the breast, is not fixed to the skin, deep tissue or nipple? what are the advantages and disadvantages of the options?
- Mastectomy
- Radical (Halsted) - removal of breast, axillary lymph nodes and both pectoralis muscles - No longer indicated
- Modified Radical (Patey) Mastectomy: Similar to radical but with preservation of pectoralis major
- simple mastectomy: removal of the breast with no dissection of the axilla, except for the region of axillary tail, which usually has a few nodes attached to it in the anterior group - standard for invasive breast cancer
- Breast Conserving Surgery (“Lumpectomy”)
- Wide local excision: remove tumour with 1cm macroscopic margin of normal breast tissue.
- quadrantecomy: removal of an anatomic quadrant
- what are the advantages and disadvantages of mastectomy?
- advantages
- No post-op RT needed unless high risk cancer
- Lower rates of local recurrence
- Can have reconstructive surgery
- No follow-up imaging needed for that side
- Psychologically better re: recurrence fears
- Better for small breasts
- disadvantages
- Longer operation
- Poorer cosmesis
- Psychological impact on appearance and sexual dysfunction
- what are the advantages and disadvantages of lumpectomy
- advantages
- Similar survival benefits
- Preservation of breast shape and skin
- Shorter operation
- Psychological advantage for appearance
- disadvantages
- Needs post-op RT
- Higher rates of local recurrence
- May need re-operation for margins
- Quadrantectomy has poor cosmetic outcome
- What are important differential diagnoses for a breast lump?
- Common
- Fibroadenoma
- Fibrocystic breast
- Fat necrosis
- Intraductal papilloma
- Breast abscess
- Atypical ductal hyperplasia (ADH) and atypical lobular hyperplasia (ALH)
- Invasive breast cancer
- Ductal carcinoma in-situ
- Uncommon
- Phyllodes tumor
- Adenoma
- Radial scar
- Lobar carcinoma in situ (LCIS)
- What is the influence of a patients age on the choice of imaging for breast cancer?
In women >30 years breast lump should have diagnostic mammogram plus ultrasound to increase diagnostic accuracy, better characterize lesions and identify the presence of satellite lesions.
- Mammography has a high false positive rate in young patients
In women <30 years – USS is the investigation of choice because the presence of denser breast tissue make evaluation with mammography less useful. Another consideration is the radiation to the breast tissue of younger women if mammography is performed.
- USS Is most useful for Cystic lesions
MRI is the most sensitive investigation for breast cancer and the non-ionising nature makes it ideal for younger patients, however it is expensive and relatively less available and therefore not largely used.
- A 26 year old woman presents to the ED with a painful, hot swollen left breast. she is 5 week spost partum with her first child and has been breast feeding successfully. She was prescribed anti-biotics for the problem 5 days ago by her GP but has been getting worse. she has no systemic previous medical hx, and takes no regular medications.
Check for sepsis:
- SIRS criteria:
- HR > 90bpm
- Temperature > 38˚C or < 36 ˚C
- RR > 20 or PaO2 < 32mmHg (< 4.2kPa)
- WCC > 12 or < 4
Lactational mastitis: usually occurs in first 3 months of breast feeding
- Risk factors;
- Cracked nipple
- Poor feeding technique
- Organism
- Staph. Aureus
- Typical presentation
- Pain, swelling, erythema
- Tx
- Simple analgesia: paracetamol or NSAIDs
- Empirical antibiotics (flucloxacillin)
- Continued feeding or milk expression
- If septic, IV antibiotics
- If abscess develops, should be drained with repeated US-guided aspiration until resolution.
- Surgery only if skin is threatened or necrotic
- How would you go about investigating a 16 year old girl who presented to you having found a lump, about 2cm across, in her left breast?
History:
- Duration – when and how was the lump first noticed
- Change – has the lump gotten bigger/ smaller, does it change with the menstrual cycle
- Trauma – accidental or iatrogenic breast trauma
- Pain – is the lump painful
- Skin changes – erythema, skin puckering
- Nipple changes – inversion, distortion, discharge
- Risk factors – previous breast lesions, FHx of breast cancer, menarche, menstrual history and OCP use, smoking, alcohol, pregnant?
- Systemic symptoms – weight loss, fever, night sweats, back pain, neurological changes, SOB, cough etc.
Inspection and examination with chaperone present
Document details of any findings – size, shape, consistency, mobility, tenderness, fixation and exact position
Management ‘
- Benign breast lumps are very common in this age group, so it’s important to provide reassurance while ruling out breast cancer.
- An appropriate management strategy can be to watch and wait to see if the lump resolves over the period of 2-3 menstrual cycles
- If lump has not resolved then USS should be performed.
Most likely fibroadenoma
- Localized form of ANDI (abnormalities of normal development and involution).
- Smooth, firm, highly mobile
- Larger fibroadenomas should be distinguished from benign phyllodes tumours.
- A 30 yao woman presented with a painful lump in her left breast 5 days after childbirth. This is a photograph of the breast. What do you see?
Describe lesion:
- Location on a clock face or quadrant
- Size and symmetry when compared to the other breast
- Erythema
- Purulence
Likely diagnosis: (in picture)
- What is the most likely organism that might be causing acute, lactation associated, breast abscess?
- Commensal skin bacterium. Almost always Staphylococcus Aureus.
- Enters through lactiferous duct or nipple trauma (cracks, fissures).
- What is the management of an acute lactation associated breast abscess
- Mastitis
- Rf: cracked nipple, poor feeding technique causing milk stasis
- Flucloxacillin 500mg PO, 6hr x 5 days
- Continued feeding and milk expression
- Paracetamol or ibuprofen for pain control
- In persistent cases: midstream milk sample MCS, and consider treating for MRSA.
- US, and biopsy if palpable mass remains after the infection is cleared.
- Abscess
- Flucloxacillin
- Refer to surgeon for needle aspiration to drain abscess
- Incision and drainage if not effected.
- Can occur with mastitis except a fluctuant mass is palpable
- a 34 yoa woman presented with a painful lump in her left breast 5 days after childbirth. This is a photograph of the breast. What is the likely diagnosis and what is the management?
Describe the lesion:
- Location on a clock face or quadrant
- Size and symmetry when compared to the other breast
- Erythema
- Purulence
Likely diagnosis – Lactation mastitis +/- breast abscess
DDx: Galactocele (usually non-painful), Inflammatory breast cancer
Management:
- Continued breast feeding/ expression of milk
- Simple analgesia
- Education and reassurance
- Antibiotics (flucloxacillin)
- Aspiration with USS guidance or surgical incision and drainage – milk and pus aspirated should be sent for MCS
- A 50 year old woman is diagnosed with breast cancer. Her surgeon recommends a “lumpectomy” and sentinel node biopsy. The pathology report shows a 20mm grade 3 ER positive, PR positive, HER-2 Negative cancer, without lymphovascular invasion, and a negative sentinel node biopsy.
A) Describe three “adjuvant” treatments that would be potentially beneficial to her
Hormonal Therapy, Chemotherapy, Radiotherapy
Hormonal tx: tamoxifen, Aromotase Inhibitors
Chemotherapy:
- Improves disease free survival in high-risk patients.
- Assess the risk of cancer returning, thereby causing morbidity (local recurrence) or death (ultimately the result of distant metastases because, although these can be treated, patients are never cured). www.adjuvantonline.cmo
- Estimate the degree to which risk can be reduced by various modalities of adjuvant treatment (hormones, chemotherapy and biological therapy), weighed up against potential toxicity.
- Assess the willingness of the patient to accept toxicity for the predicted benefit.
- Agents
- Anthracyclines - Doxorubicin and epirubicin
- Taxanes - Paclitaxel, docetaxel and nab-paclitaxel).
- Alkylating agents – cyclophosphamide, carboplatin
- Antimetabolites – 5-fluorouracil, methotrexate
- Microscopic mets.
- Better for post-menopausal
radiotherapy
- Radiotherapy is aimed at achieving local disease control (i.e. preventing local recurrence)
- This case requires RT due to the surgical technique being breast conserving (wide local excision), however if she had had a mastectomy with high risk features she would also need RT
- RT is usually external beam with either opposed tangential beams, or the more modern techniques of conformal therapy with IMRT and respiratory gating
- Usually: 40 - 50Gy/ 15 - 25# (other fractionation schedule options and booster fields depending on the disease)
- RT usually starts between 3 - 6 weeks after surgery
- A 50 year old woman is diagnosed with breast cancer. Her surgeon recommends a “lumpectomy” and sentinel node biopsy. The pathology report shows a 20 mm grade 3 ER positive, PR positive, Her-2 negative cancer, without lymphovascular invasion, and a negative sentinel node biopsy.
b) Referring to the aims of each treatment and distinguishing between the aims of adjuvant systemic therapy and adjuvant local therapy.
Adjuvant Radiotherapy – aimed at achieving local disease control (preventing local recurrence)
Adjuvant Hormonal Therapy – Systemic control
Adjuvant chemotherapy – systemic control
- A 30 year old man presents with a 3.2mm melanoma on his right arm. A wide excision and sentinel node biopsy is performed. One node is removed from the right axilla as part of the sentinel node procedure. It contains a 0.3mm deposit of melanoma.
What are the biological argumens for and against proceeding to an axillary clearance?
- Arguments for axillary clearance
- There is a high risk of micrometastases in other lymph nodes and therefore completion lymph node dissection should be performed over partial dissection or sampling.
- There are improved mortality rates for patients that undergo axillary dissection, compared to those who don’t.
- Completion lymph-node dissection has improved regional disease control and allows more precise staging and prognostic information which will influence decisions regarding adjuvant systemic therapy
- Arguments against axillary clearance
- MSLT-II trial showed no survival benefit for patients who underwent immediate completion lymph node dissection, when compared to patients who were observed and only underwent operation when lymph node involvement was clinically detectable.
- Side effects of axillary clearance include: wound infection, seroma formation, shoulder dysfunction, lymphoedema, paraesthesia
- A 53 year old man presents with a pearly nodule on his back that has, according to the patient “come up fairly quickly in the last 6 weeks”. It is bleeding when he rubs it with a towel.
Q1) How should you manage this problem?
Features of malignant melanoma
- Increase in pigmentation
- Increase in size
- Bleeding
- Ulceration or crusting
- Spread of pigmentation
- Satellite or in-transit lesions
- Pain or itching
BBC – Most common but least lethal
- Pearly appearing rolled border
- Develop from basal cell layer skin
- UV à Thymine dimer à damages DNA
- Slowly growing plaque or nodule
- skin colored, pink or pigmented
- Spontaneous bleeding or ulceration
- Nodular BCC: most common type of facial BCC. Shiny or pearly nodule with smooth surface. Central depression or ulceration so its edges appear rolled. Blood vessels across surface.
- Superficial BCC: most common type in younger adults, upper trunk and shoulders, slightly scaly, irregular plaque, thin, translucent rolled border, multiple microerosion.
History
- When did it start?
- Where did it start? Where is it now?
- Have you had it before?
- How has it changed?
- It is evolving or stable?
- Any discharge or bleeding?
- Pain, itch, dryness, altered sensation?
- Any obvious triggers or exacerbating factors? (sunlight, temperature, substances, work)
- Relieving factors?
- What treatments have been tried?
- Systemic symptoms? (fever, weight loss, malaise, joint pain, cough, cold, sore throat.
Examination
CCCSSSFFFTTT
Size, Shape, Site
Contours, Colour, Consistency
Temperature, Tender, Transluminate (fluid vs mass)
Fluctuate, Feel of drainage in lymph, Firm
Check all skin for other lesions
Biopsy
- excision biopsy with 2-5 mm margins
- punch biopsy if large lesion
- cryotherapy (double freeze thaw technique)
- radiotherapy (if margins where not cleared)
- A 55 year old woman presents with breast lump.
A) What clinical and mammographic features together would allow you to be sure that it is benign?
Benign:
Clinical features:
- Painful
- Fluctuating/ cyclical
- Smooth/ regular borders
- Firm/ rubbery
- Mobile
- Absence of skin changes, nipple changes and axillary lymphadenopathy
- Discharge is milky/ clear/ green (not bloody)
Mammographic features:
- Well circumscribed lesion
- Large, course calcifications “clunky” (i.e. not spiculated) – absence of microcalcification
- Fatty/ low density
Ultrasound Features:
- Smooth margins
- Oval
- Wider than they are tall
- Macro-lobulation
- Clearly defined margins
- Posterior enhancement
- Anechoic lesion
note:
- To be sure that a lesion is benign a triple assessment should be performed (clinical assessment, imaging and biopsy)
- The imaging findings would be classified using the Breast Imaging-Reporting and Data System (BIRADS) to determine risk of malignancy and further management and investigation
- A 45 year old woman presents with a new breast lump that she has only just noticed.
A) What single investigation might allow you to reassure her, and what finding on that investigation would be most reassuring?
All women should undergo triple therapy at a breast clinic on the same day (Clinical Assessment, imaging and tissue biopsy) on the same day
- 99.6% accuracy when performed by experienced personnel.
Single investigation: USS guided core biopsy
- 97% sensitive.
- A 36 year old woman has a mastectomy and axillary clearance for a large “triple negative” breast cancer with multiple nodes involved. She is offered adjuvant chemotherapy which should provide a relative risk reduction of about 25%. Without treatment, this woman’s chances of 5 year survival are 20%.
A) what are her chances of survival with the adjuvant chemotherapy? Explain how you arrived at this answer
5 year survival without treatment = 20%
AR (C) = 80%
RRR = 25%
AR (T) = absolute risk in treatment group
AR (T) = AR(C) – AR(C)xRRR
= 0.8 - 0.8 x 0.25
= 0.8 – 0.2
= 0.6
Absolute risk of death at 5 years in treatment group with treatment is 60%
Thus 5 year survival is 40% in treatment group
- A 50 year old woman has a wide excision and sentinel node biopsy for a brest cancer. The pathology report shows a 30mm grade 3 ER positive, PR positive, HER-2 negative cancer, without lymphovascular invasion, and a negative sentinel node biopsy. Describe the adjuvant treatment options available to her. Refer to the different aims of adjuvant systemic therapy and adjuvant local therapy
- Treatment plan of all patients should be discussed at MDT meetings
Adjuvant Radiotherapy
- Radiotherapy is aimed at achieving local disease control (i.e. preventing local recurrence)
- This case requires RT due to the surgical technique being breast conserving (wide local excision), however if she had had a mastectomy with high risk features she would also need RT
- RT is usually external beam with either opposed tangential beams, or the more modern techniques of conformal therapy with IMRT and respiratory gating
- Usually: 40 - 50Gy/ 15 - 25# (other fractionation schedule options and booster fields depending on the disease)
- RT usually starts between 3 - 6 weeks after surgery
Adjuvant Hormonal Therapy
- This woman’s tumour is ER +ve / PR +ve / HER2 -ve, therefore she should be given hormonal treatment to target the ER (e.g. SERM or aromatase inhibitor, depending on whether she is pre- or post-menopausal)
- These treatments are systemic treatment
- SERM (e.g. Tamoxifen) – used in pre- and perimenopausal women
- Competitively binds to the oestrogen receptor and therefore limits the stimulation of growth (antagonist in the breast but agonist in the bone and endometrium
- Main side effects: menopausal symptoms (vaginal dryness, hot flushes), increased risk of VTE and increased risk of endometrial cancer, which is significant after 5 years of treatment
- Reduction in mortality of 26% and up to 47% reduction in local recurrence at 10 years
- Stop treatment after 5 years and switch to aromatase inhibitor for 5 years
- Aromatase Inhibitors (e.g. Anastrozole, Letrozole, Exemestane) – used in post-menopausal women
- These drug block the conversion of androgens to oestrogens in peripheral adipose tissue and reduce the stimulation of the tumour
- Main side effects: worsening menopausal symptoms (hot flushes, osteoporosis, vaginal dryness), arthralgia and myalgia
- Patient should have their bone health check regularly – increased risk of fractures
- Ovarian suppression (e.g. Goserelin [GnRH agonist], oophorectomy) – used in treatment of pre- and perimenopausal women
- GnRH increases LH/FSH, which if continuous leads to sustained inhibition of gonadotropins and supressed ovarian steroidogenesis
- Note: if she were HER2 +ve then Trastuzumab (Herceptin) would have also been included
Adjuvant Chemotherapy
- Systemic chemotherapy should be considered due to the high grade of the lesion, even though the SNB was negative
- Mechanism is disruption of the cell cycle
- There are many different regimens of cytotoxic agents used to treat breast cancer
- Examples of cytotoxic medications:
- Anthracyclines – doxorubicin and epirubicin
- Alkylating Agents – cyclophosphamide, carboplatin
- Antimetabolites – 5-fluorouracil, methotrexate
- Taxanes – paclitaxel and docetaxel
- The use of adjuvant chemotherapy is usually reserved for those patients with poor prognostic indicators such as:
- Large tumour size
- Node positivity
- Grade 3 tumours
- Extensive lymphovascular invasionp
- How are anal fissures treated?
Conservative or operatively.
Conservative
- Topical gylerceryl trinitrate (GTN) ointment 0.2-0.4%, applied 3 times a day for a month.
- Relaxes sphincter spasm
- Increases blood supply to fissure allowing healing
- May cause headaches
- Diltiazem ointment
- Calcium channel blocker
- Injection of botulinum toxin into the sphincter complex
- Prevention with high-fibre diet and adequate fluids
Operative tx:
- Lateral submucous (internal) sphincterotomy
- Immediate relief
- 10-15% incidence of incontinence or flatus following procedure
- Less offered in women due to shorter sphincters and injury from childbirth
- Anal advancement flap
- Chronic refractory fissures
- Avoids sphincter muscle damage of sphincterotomy
- Lords anal stretch
- Manual dilation of the sphincter
- High rates of incontence due to sphincter damage – no longer offered.
- What is an anal fissure? How does it develop? What causes it to persist?
Anal fissure is a longitudinal tear in the mucosa and skin of the anal canal, sometimes caused in the passing of a large, constipated stool.
- Tear is usually posterior midline of the anal margin
- Causes acute pain and sphincter spasm, small amount of fresh blood, exacerbated by defecation
- Loop of fear of defecation worsening the constipation
- Development related to ischaemia
- Rate of perfusion is inversely related to the anal pressure.
- Primary – local trauma
- Contripation
- Diarrhea
- Vaginal delivery
- Anal sex
- Secondary
- Crohn disease
- Other granulomatous diseases
- Malignancy (anal SCC, leukemia)
- How would you go about investigating a previously well 63 yoa man who presented to you with a short history of rectal bleeding?
- ACBDE
- Haemodynamic status
- Hypotension, tachycardia, cool peripheries, tachypnoea, decrease consciousness.
- Resuscitation is priority
- History
- How much blood?
- Duration and requency?
- What colour?
- Mixed with stool? Streaked on stool? Separate? Seen only on toilet paper?
- Pain or prolapse on defecation?
- Tenesmus?
- Change in bowel habits?
- Weight loss?
- Symptoms of anaemia?
- Past medical hx
- Previous rectal bleeding
- Previous colonoscopy
- UC?
- Bowel trauma?
- Aortic surgery?
- Radiotherapy for the rectum?
- Bleeding tendency?
- Hx of disease predisposing to upper GI bleeds (PUD, chronic liver disease)?
- Meds
- Anticoagulants? Antiplatelets?
- PUD – NSAIDs/steroids/bisphosphonates
- Infective colitis – Abx – C. Difficile
- Fhx:
- Colorectal cancer
- Bowel diseases
- Shx
- Smoking
- Travel hx
- Systems review
- Examination
- General
- Vitals
- Signs of shock
- Signs of chronic blood loss (anaemia – pallor, koilonychia, SOB
- Signs of malignancy (cachexia, lymphadenopathy)
- Abdominal examination
- Tenderness/masses/organomegaly/ascites
- Rectal examination
- Inspect the anus
- Anal fissue +- skin tags +- sentinel pile, haemorrhoid, fistula
- Blood on withdrawn finger
- Inspect the anus
- General
- Investigations
- FBC, UEC, LFTs, COags, CRP,
- Proctoscopy +/- sigmoidoscopy
- Gastroscopy and colonoscopy
- Mesenteric angiography
- Radionuclide imaging
- Laparotomy and subtotal colectomy (if patient unstable)
- How would you go about investigating a previously well 63 yoa man who presented to you with a short history of anaemia?
- Anaemia is a state where the level of Hb in the blood is below the reference range for age and sex:
- Men (130 – 180 g/L)
- Women (115 – 165 g/L)
- Iron deficiency anaemia is the most common type worldwide
Mechanisms
- Disorder of production
- Bone marrow failure - e.g. aplastic anaemia, red cell aplasia
- Decreased Erythropoeitin - e.g. Chronic Kidney Disease
- Disorder of maturation
- Nuclear maturation defects - e.g. B12 or folate deficiency, myelodysplasias
- Cytoplasmic maturation defects - e.g. iron deficiency, thalassaemia
- Decreased Survival
- Inherited defects - e.g. spherocytosis, G6PD deficiency, sickle-cell anaemia
- Acquired defects - e.g. Autoimmune haemolysis, malaria, DIC, TTP
- Sequestration in spleen – hypersplenism
History:
- Symptoms of anaemia:
- Fatigue, lethargy, muscle weakness, headaches
- Dyspnoea
- Palpitations
- Worsening of vascular disease
- GI disturbance – anorexia, nausea, bowel irregularity
- Irregular menstrual pattern
- Blood Loss and risk factors:
- GI bleeding (PR bleeding, hematemesis, melaena, menorrhagia [if female])
- NSAIDs, aspirin, colon polyps of previous colonoscopy, HHT
- Gastrointestinal Surgery/ Disease:
- Gastrectomy or ileal resection
- Small bowel resection
- GORD/ PUD
- Diverticulosis
- IBD (Crohn’s or UC) or Coeliac disease
Examination:
- General:
- Vitals (HR, RR, BP, Temp, SaO2)
- Pallor
- Jaundice, icterus
- Angular stomatitis
- Koilonychia
- Abdominal
- Hepatomegaly
- Splenomegaly
- Masses
- PR exam
- Neurological examination
- Cardiorespiratory examination
Diet:
- How often does he eat red meat
- Green vegetables
- PMHx:
- Chronic infections or inflammatory diseases
- Bleeding disorders
- Meds:
- NSAIDs, aspirin
- Anticoagulants and antiplatelets
- FHx:
- Colorectal Cancer
- GI disorders
- Blood disorders
- SHx:
- Smoking
- ETOH
Investigations:
- FBC (Hb, MCV, WBC, Blood film, reticulocyte count)
- Coagulation studies
- Once anaemia is confirmed and the RBC morphology is determined, then focused investigations can be aimed at the most likely differential diagnoses
- Iron studies (serum iron, ferritin, TIBC & transferrin), serum B12 and folate, haemolytic parameters (serum LDH, haptoglobin, bilirubin), Direct Coomb’s test, Hb Electrophoresis
- FOBT
- Urinalysis and Urine MCS
- Gastroscopy and colonoscopy
- Small bowel capsule endoscopy
- How would you go about investigating a previously well 63 yoa man who presented to you with a short history of a change in bowel habit to more frequent evacuation of loose stools with mucus?
History
- Onset & duration
- How much stool and mucus
- Consistency and appearance of stool
- Light coloured, floating?
- Foul smelling
- Bleeding?
- Any abdominal pain or pain on defecation
- Relation to meals?
- Tenesmus?
- Fever, sweats, hot and cold, shivers?
- Unintentional weight loss? Fatigue?
- Any recent travel?
- Any other people unwell?
- PMHx – Colonoscopy? Bowel surgery? IBD?
- Laxative use? Recent abx?
- SHx: smoking, EtOH, recreational/IV drugs, change in diet,
- FHx: GI disease, colorectal cancer
Examination:
- General appearance: well/unwell, nutritional status
- Vitals (HR, RR, BP, temp, SaO2
- Assess fluids
- Mucous membranes
- Capillary refill
- JVP
- CVS/Resp
- Abdo exam
Investigations
- FBC + iron studies, folate, B12 (anaemia)
- UEC, LFT, CMP, coagulation studies
- Stool MCS (leukocytes, occult blood, ova/parasites)
- Stool PCR for C. Difficile toxin
- Colonoscopy/ ?CT colonography
- What are the major risk factors for colorectal cancer?
Major
- Increasing age (>60yrs)
- Western diet (low fibre, high fat)
- Ulcerative colitis
- Polyposis syndromes
- Familial adenomatous polyposis
- Peutz-jeghers syndrome – hamartomatous polyps
- Hereditary non-polyposis colorectal cancer (HNPCC)
- Central obesity
- Physical activity
- EtOH
- Family hx of colorectal cancer with young age at diagnosis
- Hx of polyps =/- adenomas
- What method is used for population screening for Colorectal cancer in Australia?
Faecal occult blood test
- 50-74yrs
- For low-risk people with no symptoms
- Screening kits are mailed to residents
- 2 yearly – kits received 6 months within birthday at 50, 52, 54, … ,
- What is the neoadjuvant therapy for rectal cancer?
Chemoradiotherapy to shrink the tumour to improve the chances of surgical removal.
- Offered to Dukes C cancers (stage III)
- Chemoradiotherapy in rectal tumours tethered in the pelvis
- Radiotherapy where rectal cancers extend through the bowel wall anteriorly to reduce local recurrence
- Chemotherapy in large bowel cancer – 5-fluorouracil (5-FU) is the primary agent, given in combination with bimodulator folinic acid.
- Where are the common sites that metastatic disease from colorectal primary are found?
- Liver most common
- Lungs 2nd most common
- Bone
- Peritoneum
- What are the treatment options for liver metastases from a colorectal primary?
- Majority of patients cannot be cured and intent of treatment is usually palliative
- If mets are localized to one anatomical lobe it may be resected. – partial hepatectomy
- PET scan to esclude extra-hapatic metastases
- Exclusion criteria
- Extrahepatic metastases
- Radiographic evidence of involvement of the common hepatic artery, common bile duct or portal vein
- Extensive liver involvement (>70%, or >6 segments, or involvement of all 3 hepatic veins)
- Inadequate predicted post-resection functional hepatic reserve
- Patient not fit for surgery
- Oral dexamethasone may temporarily reduce metastatic tissue edema and relieve symptoms
- Neoadjuvant chemotherapy to allow a tumour to become resectable
- Radiofrequency ablation
- Hepatic intra-arterial chemotherapy
- Radiotherapy
- What is the adenoma-carcinoma sequence?
- Adenoma-carcinoma sequence refers to a stepwise pattern of mutation in a cell or group of cells that results in cancer
- Mutations include
- Activation of oncogenes from proto-oncogenes (e.g. K-RAS)
- Inactivation of tumour suppressor genes (e.g. p53, APC)
- The classic adenoma-carcinoma sequence accounts for 80% of sporadic colon tumours and typically includes mutation of APC early in the process
- Supporting evidence of this model [Uptodate]
- Early carcinomas are frequently seen within large adenomatous polyps, and areas of adenomatous change can often be found surrounding human CRCs
- Adenomas and carcinomas are found in similar distributions throughout the large bowel, and adenomas are typically observed 10 to 15 years prior to the onset of cancer in both sporadic and familial cases.
- In animal models, adenomas develop before carcinomas, and carcinomas develop exclusively in adenomatous tissue
- The ability to reduce the incidence of CRC through the removal of polyp has been shown in controlled trials in humans.
- What is Crohn’s disease?
chronic relapsing inflammatory disorder of any part of the gastrointestinal tract (though nearly always small or large bowel
- 60% under 25 years of diagnosis
- Skip lesions
- Small bowel 50%, large bowel 20%, both 30%
- Terminal ileum most common
- Commonly affects the perianal region regardless of large bowel involvement
- Transmural inflammation
- May partially obstruct, fistulate or perforate, whereas this rarely occurs in UC.
- With each exacerbation, previously affected or new areas may become involved.
- Pathophysiology
- Transmural inflammation
- Marked thickened inflammatory oedema, especially in the submucosa.
- Fissured ulcers à cobblestoning
- Granulomas
- Multinulceate giant cells
- Fibrosis à elongated strictures
- Requires histological and microbacterial differentiation from yersinia ileitis and tuberculosis
- Serosal inflammation à adhesions, perforation, fistulae
- Perianal inflammation 15%
- Recurrent perineal abscess, characteristic bluish boggy ‘piles’.
- Ix
- Colonoscopy & biopsy
- Barium follow through
- Tx
- Anti-inflammatories
- 5-ASA compounds – sulfasalazine, mesalazine
- Corticosteroids
- Immunomodulators
- Azathioprine and 6 -mercaptopurine
- Methotrexate
- Infliximab
- Other supportive therapy
- Antidiarrhoeal and antispasmodics
- Dietary modification
- Liquid/low fibre in those with obstructive symptoms
- Supplementary calories
- Iron and vitamins
- Anti-inflammatories
- Surgery
- Not curative in crohns as operating on one portion of the bowel does not prevent recurrences elsewhere
- Crohns fissure – atypical
- Heaped up edges
- Multiplicity
- >1cm
- Not 6oClock
- What is diverticular disease?
- Colonic circular muscle is thickened because of an excess of elastic tissue between muscle fibres rather than muscle hypertrophy
- Hypersegmentation -> causes peristatltic waves at each other -> high intraluminal pressure in short segments -> mucosa herniates through weak points
- What is diverticulitis? How does it present clinically?
- Chronic grumbling diverticular pain
- Periverticular inflammation is chronic, low-grade, and recurrent. Local irritation provokes bowel wall spasm, causing bowel pain and erratic bowel habit.
- Mild iliac fossa tenderness and faecal loading
- Endoscopy or imaging
- Relieved by taking a high-fibre diet
- Acute diverticulitis
- Continuous left iliac fossa pain, pyrexia, tachycardia.
- Left iliac fossa tenderness to obvious local peritonitis
- Abx: ciprofloxacin and metronidazole
- Bowel rests with NBM
- Hinchey classification of abscess and perforation
- Stage 1: small pericolic or mesenteric abscess <4cm
- Stage 2: large, pelvix abscess
- Stage 3: small perforation causing gaseous and purulent peritonitis
- Stage 4: free rupture with faecal peritonitis
- Pericolic abscess
- Fails to reverse with abx
- Persistent pain, swinging pyrexia, incomplete obstruction due to spasm of bowel wall muscle.
- May drain into bowel causing diarrhea
- CT scan
- Abx
- Diverticular perforation
- Acute abdomen
- Sub-diaphragmatic gas on CT or Xray
- Conservative treatment – percutaneous drain, bowel rest for Hinchey 3 but not Hinchey 4
- Hinchey 4 perforation requires parenteral antibiotics and laparotomy for peritoneal toilet, diversion of faecal stream and resection of diseased bowel.
- Fistula formation into other abdominal or pelvic structures
- Occurs when an inflamed diverticulum lies close to another hollow viscus
- Large bowel and small bowel causes diarrhea
- Vesico-colic fistula fistula causes pneumaturia and severe UTI
- Intestinal obstruction
- Bowel obstruction due to acute inflammatory thickening, muscle hypertrophy and spasm.
- Incomplete obstruction is more common and presents as severe constipation.
- Chronic diverticular inflammation sometimes causes local fibrous strictures, particularly in the sigmoid à which cause intermittent bouts of constipation when the stool is dry.
- Acute rectal hemorrhage
- Not common.
- Typically complains of having passed a mass of fairly fresh blood instead of the expected stool and is admitted to hospital urgently.
- Ddx: ischaemic colitis
- What are the major complications that can result from diverticulitis?
- Spreading pericolic inflammation
- Pericolic abscess
- Intraperitoneal perforation
- Fistula formation into other abdominal or pelvic viscera
- Bowel-to-bowel adhesions
- Fibrous strictures of the bowel
- Acute haemorrhage (which tends to occur without inflammation)
- What are haemorrhoids and how are they classified or described?
Definition:
- Engorged normal vascular structures located in the submucosal layer of the anal canal
- Arise from a plexus or cushion of dilated arteriovenous channels ad connective tissue that drain into the superior, middle or inferior hemorrhoidal veins
- They are normally located in the left lateral, posterior and right anterior positions (3,7,11 oClock).
- They only become an issue if they are symptomatic
Classification:
- First degree (or grade 1): never prolapse
- Second degree (or grade 2): prolapse during defecation and then return spontaneously
- Third degree (or grade 3): remain outside the margin unless replaced digitally.
Anatomical classification :
- Most considered ‘internal’ because they are covered by glandular mucosa.
- Large neglected haemorrhoids may extend beneath stratified squamous epithelium so their lower part becomes covered by skin. ‘intero-external’ haemorrhoids.
- How are symptomatic haemorrhoids treated?
Conservative management:
- Prevetion
- High fibre diet
- Avoid straining
- Spend minimal time defecating
- 3rd degree
- Patient replacing the prolaping haemorrhoids digitally after defecation
- Creams, suppositories, and other topial preparations available
- Some contain local anaesthetic agents or steroids
Surgical management
- Injection of sclerosants or banding
- First degree and most second degree as outpatient
- Sclerotherapy
- 1-3ml of mildly irritant solution – 5% phenol in oil injected submucosally around the pedicles of three major hemorrhoids in the insensitive upper anal canal à fibrotic reaction à obliterates haemorrhoidal vessels and causing atrophy of the haemorrhoids.
- Repeated 4-6wks 2-3 times.
- Banding
- Cone of mucosa kist above the haemorrhoid neck is drawn into a banding instrument, often by suction, and tight elastic bands released around the base of a cone, constricting the haemorrhoidal vessels.
- Haemorrhoid gradually shrinks.
- Haemorrhoidectomy
- Haemorrhoidal excision
- Third degree or tx failed
- Miligan and morgan
- Haemorrhoidal masses and overlying mucosa = skin excised
- Healing by secondary intention and wound contraction
- Stapeled hemorrhoidectomy
- Popularity for large haemorrhoids
- Excising ring of low rectal mucosa. Including the engorged necks of the piles
- The metal staple line remains in situ.
- Haemorrhoidal excision
- Hemorrhoidal artery ligation operation
- New procedure
- US each artery supplying haemorrhoid, encircle with stitch via the insensitive lower rectal mucosa to cut off its blood supply -à haemorrhoids shrink, bleeding and local symptoms ablate, although skin tags remain.